What's new?

Article

Spring has finally sprung, although I have a feeling that the pleasant weather associated with this season has decided to give England a miss this year! Indeed, we are already into the month of May and with several big ophthalmology meetings already behind us, we still have many others to look forward to, particularly this month, which sees, amongst others, the DOC, EURETINA, and the Turkish, French and Italian ophthalmology societies taking centre stage for their annual meetings. Hopefully we will get the chance to meet some of you there.

In this month's issue, we are presenting an article that deviates from our norm. What's in the pipeline? is a showcase of just some of the products that you may be using already or may consider adopting in the future. With research and development in ophthalmology moving at such a rapid pace, it is impossible to display all of those technologies, which are making an impact in your practice. However, we do hope that we can offer you a flavour of where your market is going and what the manufacturers are up to.

Elsewhere, Einar Stefánsson speaks of blindness among the diabetic population and questions why this still affects so many people when early screening could lead to prevention and cost savings in the long run. This month also sees Khiun Tjia updating us on his experience with, what many believe, is a revolutionary method of performing microincisional cataract surgery. Torsional ultrasound is an exciting new innovation in phacoemulsification, which could transform your surgical practice. Take a look and form your own decision.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.